/
MASHIV Multi-Agent Simulation of HIV in MSM Communities MASHIV Multi-Agent Simulation of HIV in MSM Communities

MASHIV Multi-Agent Simulation of HIV in MSM Communities - PowerPoint Presentation

laxreffa
laxreffa . @laxreffa
Follow
342 views
Uploaded On 2020-08-05

MASHIV Multi-Agent Simulation of HIV in MSM Communities - PPT Presentation

A Study of Concurrency Robert Puckett UH Manoa November 20 2014 Outline Core Concepts HIV Concurrency MSM Agents MASHIV System Design HIV Model Agents Sexual Negotiation Modes of ID: 799379

agent hiv mashiv msm hiv agent msm mashiv risk transmission multi sexual amp agents relationships progression phi simulation mortality

Share:

Link:

Embed:

Download Presentation from below link

Download The PPT/PDF document "MASHIV Multi-Agent Simulation of HIV in ..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

MASHIV

Multi-Agent Simulation of HIV in MSM CommunitiesA Study of Concurrency

Robert Puckett, UH

Manoa

, November 20, 2014

Slide2

Outline

Core ConceptsHIVConcurrencyMSMAgents

MASHIV

System Design

HIV ModelAgentsSexual NegotiationModes of OperationQ & A

2

Slide3

Research Questions

Can a multi-agent simulation of individual level HIV transmission illuminate the impact that concurrent sexual relationships have on the HIV epidemic in MSM communities?What is the impact of PrEP amid concurrency

on the

resulting HIV epidemic?

Can we overcome stochastic variability to provide consistent analysis and recommendations?3

Slide4

Core concepts

Really Quick Overview

Slide5

HIV Stages

Primary/Acute HIV Infection (PHI)Virulence: HighEstimated 43% of infections due to PHI period [Wawer]

Occurs 2-4 weeks after exposure

Duration: 1.5 – 12 months

[Blaser, 2013]Only 2/3 experience symptomsFever, fatigue, pharyngitis, weight loss, night sweats, lymphadenopathy, myalgia, headache, nausea

Symptoms commonly result in misdiagnosis

Correctly diagnosed as PHI in 1000 of 60 million cases

HIV undetectable by antibody tests for several weeks into PHI

[

Coplan

]

5

Slide6

HIV Stages

Asymptomatic PeriodVirulence: Low, but presentDuration: 8+ years, untreatedAcquired Immuno-deficiency Syndrome (AIDS)

Immune system badly damaged (CD4 count < 200)

Susceptible to

Opportunistic infectionsCertain cancersLife expectancy1-3 years depending on presence of opportunistic infections

6

Slide7

Viral Plasma Load by Stage

7

Slide8

Concurrency

”Overlapping sexual partnerships where sexual intercourse with one partner occurs between two acts of intercourse with another partner.” [UNAIDS, 2009]Key ComponentsDuration of relationships

Contact frequency

Number of partners

Virulence of partners

Serial Monogamy

Concurrent partnerships

1

2

3

4

5

time

1

2

3

4

5

time

8

Slide9

Concurrency & PHI

The concernConcurrent relationships will create a highly connected/reachable sexual networkPHI stage is highly virulent, unlikely to be detectedResult

Waves of PHI stage HIV infection sweep through sexual network

concurrency

monogamy

9

Slide10

The MSM Community

MSM – Behavior specific termIncludes gay, bisexual, male sex workers, transgenderedAny other men who engage in same-gendered sexStatistics

51

% of new HIV cases in the US were MSM

14-19% of urban MSM are HIV+ [Goodreau 2007]HIV prevalence in MSM increasing in most developed countries since 90s [Grulich 2008]

10

Slide11

MSM & HIV Risk

Risk FactorsUnprotected Anal Receptive Sex (UAR)Disproportionately affected by STIs [Goodreau

]

Other behavioral factors

“Bareback “ sex seeking, sero-sorting, high-risk venuesHigher proportion of concurrent relationships?Concurrent relationshipsGeneral US Population: 11% of men

San Francisco urban MSM cohort: 78% of men

Note: vastly different sample populations

Less sexual role segregation

Heterosexual sexual role defined by gender

MSM sexual role defined by preference (

insertive

/receptive)

Role versatility allows HIV to spread more easily

11

Slide12

Multi-agent systems

An Overview

Slide13

What are Agents?

A programming construct meant to represent a real-life entity or roleKey characteristicsAutonomousGoal orientedSelf-organizing

Exist in / React to environment

Local knowledge

DecentralizedCompete, coordinate, cooperateIn an individual-level multi-agent simulation of HIV1 agent == 1 person

13

Slide14

Multi-Agent System

The AgentsCognitive modelPersonal history of interactions with the world/agentsThe EnvironmentObservable by the agents

Does not directly control the agents

The Rules

Actions the agents may chooseReactions to the environment/agentsGoal-oriented behaviorLimitations on agent behavior

14

Slide15

Why use Agents for HIV?

Intuitive pairing of agents and peopleSimple rules can result in complex behaviorAllows for observing the dynamics of individual-level decision making on the HIV epidemicPotentially useful for guiding real-world studies and interventions

15

Slide16

MASHIV

The Multi-Agent Simulation for HIV Transmission

Slide17

MASHIV

GoalUse JAVA to develop a multi-agent simulation of HIV for the MSM communityDetermine the role of concurrency in HIV epidemics of MSMTrack and AnalyzeHIV Prevalence/Incidence trends

Proportion of infections resulting from PHI

Concurrency measure of population over time

17

Slide18

MASHIV Operation

User defines parameter setGlobal vs. Population parameter assignmentPopulation definition

Runtime

Initialization

Process User ParametersGenerate Relationship SchemasGenerate AgentsMain LoopUpdate AgentsUpdate HIV Disease ProgressionUpdating Existing Relationships

Sex, HIV Transmission, Relationship Ending

Date & Add Relationships

Statistics Collection

18

Slide19

Parameters

19

Slide20

Person Agent

Represents an MSM personForms/Ends RelationshipsEvaluates potential partnersReacts to HIV infection

20

Slide21

Relationship Instance

Agents can have different schemas and expectations for relationship.21

Slide22

Relationship Schema

Duration vs. Probabilistic Mode22

Slide23

Relationships

Wanting to DateModesDuration-based: Time since last dateProbabilistic: Probability of formationFactors

Existing steady relationship

Number of relationships

Dating Pools10 random dating agentsSexual role compatibleBoth seeking same relationship type (Casual, Steady)Steady: no repeats; Casual: repeats allowedDating Evaluation…

23

Slide24

Dating Evaluation

24

Slide25

MASHIV hiv model

The Multi-Agent Simulation for HIV Transmission

Slide26

HIV Model

InitializationDistributed to population based upon user inputHIVInstance is created

Transmission

Risk

Viral load of stage determines virulenceSafe sex practice determines riskProgression toward mortalityCD4 compartment model

26

Slide27

HIV Instance

Handles HIV progression & mortalityLogs key informationSource of InfectionStage of infection source

27

Slide28

HIV Transmission

28Condom UseTransmission Risk

S – Stage risk multiplier

Art() - ART risk reduction

Slide29

HIV Transmission

29

Reception Risk

P

() : Sexual role riskPrEP

() –

PrEP

risk reduction

Circ

() – Circumcision risk reduction

Slide30

HIV Infection

Fast-moving vs. Regular SpeedVirus StagesPHI – 90 daysAsymptomatic & AIDS

CD4 Model

30

Slide31

HIV Progression

CD4 Compartment ModelAdapted from Spectrum/EPP specification [UNAIDS]Used to progress agents from infection to death

Compartments correlate to CD4 counts of individuals

Annual progression rates define progression between compartments and compartment mortality

Reduces progression rate to account for ART usage

31

Slide32

Lambdas

32

Slide33

Mus

33

Slide34

Alphas

34

Slide35

Transmission Probabilities

Tool for viewing transmission probabilities for model35

Slide36

MASHIV Interface

A Multi-Agent Simulation of HIV

Slide37

Main Window & Menus

37

Slide38

Parameter Set

38

Slide39

Parameter Set

39

Slide40

Interactive Dash

40

Slide41

Interactive Dash - Running

41

Slide42

Interactive Dash

42

Slide43

Interactive Dash – Adding Set

43

Slide44

Aggregate Set Editor

44

Slide45

Aggregate Set - Running

45

Slide46

Aggregate Set - Running

46

Slide47

Progression in MASHIV

Analysis tool for observing Stage & Group Progression in Model47

Slide48

Mortality In MASHIV

Tool for observing mortality without ART

48

Slide49

Mortality In MASHIV

Tool for analyzing mortality with ARTGraphs represent ART started in first CD4 group assignedAssumes only mortality based ART failureLack of background mortality

49

Slide50

Q&A

Questions and Answers